These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3541134

  • 21. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.
    Washington JA, Knapp CC, Sanders CC.
    Rev Infect Dis; 1988; 10(4):824-9. PubMed ID: 3263689
    [Abstract] [Full Text] [Related]

  • 22. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM, Bonomo RA.
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [Abstract] [Full Text] [Related]

  • 23. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ, Jin YF, Turner HL.
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [Abstract] [Full Text] [Related]

  • 24. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E, Komoto E, Taniyama Y, Mitsuhashi S.
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [Abstract] [Full Text] [Related]

  • 25. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD.
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [Abstract] [Full Text] [Related]

  • 26. In-vitro activity of a new penem FCE 22101.
    Hoban DJ.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [Abstract] [Full Text] [Related]

  • 27. An explicit model for bacterial resistance: application to beta-lactam antibiotics.
    Waley SG.
    Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188
    [Abstract] [Full Text] [Related]

  • 28. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 May; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 29. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA, Hare R, Papa E, Adam C, Miller GH.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM, Wood MJ.
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [Abstract] [Full Text] [Related]

  • 31. Diversity of the mechanisms of resistance to beta-lactam antibiotics.
    Frère JM, Joris B, Granier B, Matagne A, Jacob F, Bourguignon-Bellefroid C.
    Res Microbiol; 1991 Oct; 142(6):705-10. PubMed ID: 1961980
    [Abstract] [Full Text] [Related]

  • 32. [Betalactamase inhibitors].
    Timoşca S, Liscă M.
    Rev Med Chir Soc Med Nat Iasi; 1982 Oct; 86(1):35-41. PubMed ID: 25591246
    [No Abstract] [Full Text] [Related]

  • 33. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--I. Steady-state treatment.
    Frère JM.
    Biochem Pharmacol; 1989 May 01; 38(9):1415-26. PubMed ID: 2785796
    [Abstract] [Full Text] [Related]

  • 34. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
    Thomson KS.
    Curr Pharm Des; 2013 May 01; 19(2):250-6. PubMed ID: 22894616
    [Abstract] [Full Text] [Related]

  • 35. A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic.
    Liu R, Miller PA, Vakulenko SB, Stewart NK, Boggess WC, Miller MJ.
    J Med Chem; 2018 May 10; 61(9):3845-3854. PubMed ID: 29554424
    [Abstract] [Full Text] [Related]

  • 36. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K, Macielag MJ.
    Expert Opin Ther Pat; 2010 Oct 10; 20(10):1277-93. PubMed ID: 20839927
    [Abstract] [Full Text] [Related]

  • 37. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH.
    J Antimicrob Chemother; 1987 Jun 10; 19(6):713-32. PubMed ID: 3301784
    [No Abstract] [Full Text] [Related]

  • 38. Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.
    Cherian PT, Deshpande A, Cheramie MN, Bruhn DF, Hurdle JG, Lee RE.
    J Antibiot (Tokyo); 2017 Jan 10; 70(1):65-72. PubMed ID: 27189120
    [Abstract] [Full Text] [Related]

  • 39. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
    Shibl AM.
    Chemotherapy; 1992 Jan 10; 38(5):324-9. PubMed ID: 1286574
    [Abstract] [Full Text] [Related]

  • 40. Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria.
    Costa BO, Cardoso MH, Franco OL.
    Curr Protein Pept Sci; 2020 Jan 10; 21(10):1011-1026. PubMed ID: 32933457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.